Metformin activates the SIRT3‐AMPK axis, which can help to delay cardiac dysfunction associated with the metabolic syndrome [82], but further studies are needed to see whether metformin ameliorates DCM. Here, SIRT3 is linked to familial dilated cardiomyopathy.